References
- Baraldo M. The influence of circadian rhythms on the kinetics of drugs in humans review. Expert Opin. Drug Metab. Toxicol 2008;4(2):175–92.
- Lemmer B. Recent advances in the chronopharmacology of cardiovascular diseases. In Lemmer B, Hüller H eds. Clinical chronopharmacology, klinische pharmakologie/clinical pharmacology, Vol. 6, Zuckschwerdt Verlag München Bern Wien San Francisco. 1990, 45–52.
- Lemmer B, Schelidel B, Behne S. Chronopharmacokinetics and Chronopharmacodynamics of cardiovascular active drugs: propranolol, organic nitrates, nifedipine, Ann. NY Acad. Sci. 1991;618:166–81.
- Lemmer B. Temporal aspects in the regulation of the sympathetic nervous system in rats. In Lemmer B ed. Chronopharmacology - cellular and biochemical interactions. Marcel Dekker: New York. 1989, 477–508.
- Lemmer B. Implications of chronopharmacokinetics for drug delivery: antiasthmatics - H2-blockers cardiovascular active drugs. Adv Drug Deliv Rev 1991;6:83–100.
- Leonetti G. Effects of nilvadipine and amlodipine in patient with mild to moderate essential hypertension: and double-blind, prospective, randomized clinical trial. Curr. Med. Res. Opin. 2005;21:951–58.
- Jamali SN, Mashori GR, Azmi AA, et al. Antihypertensive efficacy of cardioselective Beta-blocker atenolol and amlodipine in essential hyprtensive patients. Pak J Pharmacol 2009, March 26;2:49–54.
- Sevgi Tatar, Sedef Atmaca. Determination of amlodipine in human plasma by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. B 2001;758:305–10.
- Ji-Young Park, Kyoung-Ah Kim, Pil-Whan Park, et al. Pharmacokinetic and pharmacodynamics characteristics of a new S-amlodipine formulation in healthy Korean male subject: a randomized open-label, two-period, comparative, crossover study. Clin. Ther 2006;28:1837–47.
- Jianzhong Shentu, Lizhi Fu, Huili Zhou, et al. Determination of amlodipine in human plasma using automated online solid-phase extraction HPLC-tandem mass spectrometry: application to a bioequivalence study of Chinese volunteers. J Pharm Biomed Anal 2012(Nov);614–18. doi:10.1016/j.jpba.2012.06.014.Epub2012 Jun 19.
- Vasu Babu Ravi, Jaswanth Kumar Inamadugu, Nageswara Rao Pilli, et al. Simultaneous determination of telmisartan and amlodipine in human plasma by LC–MS/MS and its application in a human pharmacokinetic study. J Pharm Anal 2012;2(5):319–26.
- Skio F, Tsuyoshi S, Kyo-Ichi O, Akio E. Chronopharmacology of amlodipine in rats. Life Sci 1993;53:595–602.
- Meredith PA, Elliott HL. Clinical pharmacokinetics of amlodipine. Clin Pharmacokinet 1992;22:22–31.
- Faulkner JK, McGibney D, Chasseaud LF, et al. The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily. Br J Clin Pharmacol 1986;22:21–25.
- Sun JX, Cipriano A, Chan K, John VA. Pharmacokinetic interaction study between benazepril and amlodipine in healthy subjects. Eur J Clin Pharmacol 1994;47:285–89.
- Lemmer B, Luders S, Nold G, et al. Normalisation of nondipping blood pressure profile by amlodipine after single morning or evening dosing. Am J Hypertens 2002;15:109A.
- Balan H. New proofs concerning benefits from time-scheduled BP-lowering therapy. Rom J Intern Med 2011;484:225–36.